Reby Advisors’s Novartis NVS Stock Holding History

Reby Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$16K	Buy	+170	New	+$14.9K	﹤0.01%	372

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Reby Advisors's NVS Position: Q4 2020 in Review

Reby Advisors opened a new position in Novartis (NVS) in Q4 2020: 170 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #372 among its holdings.

1,176 funds tracked by Wall St. Rank hold NVS as of Q4 2020.

Reby Advisors held 170 shares of Novartis worth $16K as of Q4 2020.
Novartis was a new Reby Advisors position in Q4 2020.
Novartis made up ﹤0.01% of Reby Advisors's portfolio in Q4 2020, its #372 holding.
1,176 funds tracked by Wall St. Rank held Novartis as of Q4 2020.

Based on Reby Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.